Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Eleven programmes financed through the second Swiss Contribution, with a total value of around CHF 221.5 million (€240 million), are now in implementation in Romania.
OMV Petrom concluded a sales contract with OMV Downstream GmbH, a fully owned subsidiary of OMV AG, for part of the Sustainable Aviation Fuel (SAF) and Hydrotreated Vegetable Oil (HVO) to be produced at the Petrobrazi refinery.
Raiffeisen Asset Management (RAM) manages around 15% of the financial assets of Raiffeisen Group's individual clients in Romania, almost double the market average.
Romania registered the highest annual inflation rate in the bloc for May 2026, reaching 9.7%, according to Eurostat.
PPC Blue Romania, part of the PPC group in Romania, has signed a partnership with Dedeman, a Romanian-owned DIY retailer, for the installation and operation of electric vehicle charging stations across Dedeman's national store network, both existing and future locations.